XML 52 R37.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Components of Net Deferred Tax Assets and Liabilities

The components of the net deferred tax assets and liabilities as of December 31, 2024 and 2023, consist of the following:

 

   2024   2023 
   (in thousands) 
Deferred tax assets:  December 31, 
   2024   2023 
Net operating losses  $29,001   $25,114 
Research and Development costs   3,914    3,517 
Stock Compensation   1,515    1,479 
R&D credits   2,829    1,376 
           
Other   41    137 
Amortization & Depreciation   

5,575

    

6,791

 
Right of use asset   4    6 
Total deferred tax assets   42,879    38,420 
           
Less: Valuation allowance   (42,879)   (36,816)
Deferred tax assets, net  $   $1,604 
Schedule of Effective Tax Rate and Statutory Tax Rate

Reconciliation between the effective tax rate on income from continuing operations and the statutory tax rate is as follows (in thousands):

 

Pre Tax Book Loss  $(17,320)     
           
Federal Rate   (3,637)   21.0%
State Taxes   (1,321)   7.63%
Other Perms   1    -0.01%
RTP   396    -2.29%
Income Tax Income   459    -2.65%
State Rate Change   149    -0.86%
162(m)   126    -0.73%
R&D credits   (969)   5.59%
Mark to Market   (163)   0.94%
R&D credit addback   

261

    

-1.51

%
Loss on Fair Value Warrants   131    -0.76%
Other   108   -0.62%
Valuation Allowance   4,459    -25.75%
         
Total  $    -0.0%

 

The Company files tax returns in the U.S., Florida and New Jersey. As of December 31, 2024, tax years for 2023, 2022, and 2021 are still subject to examination by the tax authorities. The Company is no longer subject to U.S. federal or state examinations by tax authorities for years before 2021.